Stockholm - Free Realtime Quote SEK
PharmaLundensis AB (PHAL.ST)
0.5500
-0.0220
(-3.85%)
As of 9:13:58 AM GMT+2. Market Open.
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Staffan Skogvall | Founder, CEO & Director | -- | -- | 1963 |
PharmaLundensis AB
- Sector:
- Healthcare
- Industry: Biotechnology
Description
PharmaLundensis AB operates as a pharmaceutical company. The company develops Iodocarb for treating chronic obstructive pulmonary disease; and treatments for chronic bronchitis and influenza-induced lung failure. It develops EcoFilter, a system that eliminates the release of pharmaceutical drugs and multi-resistant bacteria in hospital wastewater. PharmaLundensis AB was founded in 2006 and is based in Lund, Sweden.
Corporate Governance
PharmaLundensis AB’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available